Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
14.42
-0.31 (-2.10%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Jade Biosciences Employees
Jade Biosciences had 55 employees as of December 31, 2025. The number of employees increased by 25 or 83.33% compared to the previous year.
Employees
55
Change
25
Growth
83.33%
Revenue / Employee
n/a
Profits / Employee
-$2,262,582
Market Cap
917.07M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 55 | 25 | 83.33% |
| Dec 31, 2024 | 30 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Kura Oncology | 260 |
| Alumis | 239 |
| Rigel Pharmaceuticals | 174 |
| Sana Biotechnology | 142 |
| Cullinan Therapeutics | 109 |
| Cybin | 100 |
| Apnimed | 81 |
| SpyGlass Pharma | 76 |
JBIO News
- 4 days ago - Jade Biosciences Transcript: Stifel 2026 Virtual Immunology and Inflammation Forum - Transcripts
- 12 days ago - Jade Biosciences Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 18 days ago - Jade Biosciences Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 19 days ago - Jade Biosciences Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 24 days ago - Jade Biosciences price target raised to $48 from $25 at Clear Street - TheFly
- 26 days ago - Jade Biosciences to Participate in Upcoming Conferences - GlobeNewsWire
- 6 weeks ago - Jade Biosciences price target raised to $48 from $40 at Jefferies - TheFly
- 6 weeks ago - Jade Biosciences price target raised to $47 from $45 at Wedbush - TheFly